| Previous Close | 86.56 |
| Open | 87.00 |
| Bid | 71.12 x 1000 |
| Ask | 71.74 x 44000 |
| Day's Range | 86.69 - 88.97 |
| 52 Week Range | 62.50 - 92.97 |
| Volume | 2,863,602 |
| Avg. Volume | 2,393,866 |
| Market Cap | 108B |
| Beta | 0.73 |
| PE Ratio (TTM) | 12.26 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 3.30 (3.47%) |
| Ex-Dividend Date | 2017-05-16 |
| 1y Target Est | N/A |
- Reuters•2 days ago
Worldwide drug sale forecasts fall as pricing pressures mount
Forecasts for global sales of pharmaceuticals have declined for the first time in a decade as continuing pressure on prices in the key U.S. market has caused analysts to moderate revenue expectations, according to a report on Tuesday. Evaluate Pharma, which compiles consensus numbers based on analysts' forecasts, said worldwide drug sales were now expected to hit $1.06 trillion in 2022, down from $1.12 trillion predicted a year ago for the same period. It is the first time in 10 years that total drug sales have failed to beat the previous year's forecast level.
- Financial Times•2 days ago
[$$] Global pharma sales forecasts cut amid pricing pressures
Global sales projections for the pharmaceuticals industry have been cut by a closely watched forecaster amid signs rampant drug price inflation in the US is starting to ease after years of public pressure. ...
- Zacks•2 days ago
4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio
The Zacks-categorized Large Cap Pharmaceuticals industry is among the top 21% of the 256 Zacks-ranked industries -- here is a look at 4 top-ranked stocks from this sector.
